Amivas Is A Usaustralianand European Joint Venture Focused On The Development And Commercialization Of Therapeutics For The Treatment Of Life Threatening Diseases With Offices In The Usaustralia And Irelandamivas Manufactures In North America And Our Partners In Canadausa And Europe Package And Supply Our Product To Hospitals And Patients In Need Amivasvision Was Formed In Response To The Urgent Need For A Us And Europebased Firm To Assume Responsibility For The Manufacture And Distribution Of Artesunatefor The Treatment Of Severe Malaria After Quinidine Gluconate Was Discontinued In 2019With The Us Food And Drug Administrationfdaapproval Of Its First Commercial Product On May 262020Amivas Is Proud To Join The Global Effort To Fight And Eradicate Malaria
